DHR vs LECO vs TMO Stock Comparison

Danaher, Lincoln Electric Holdings and Thermo Fisher Scientific Prices as of Nov 3, 2026 Peers: Industry group
1 more company in this comparison (QGEN) Create a free account to keep reading and compare up to 10 companies.
DHR Danaher Corp /De/
$230.08 +7.5% 1M +7.5% 1Y
Market cap
$165.27B
P/E
38.2x
Revenue (TTM)
$25.61B
Div. yield
–
Life Sciences Tools Healthcare
2 wins

Head to Head

12 decided of 12

Lincoln Electric Holdings leads on 7 of the 12 questions below (Lincoln Electric Holdings 7, Thermo Fisher Scientific 3, Danaher 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionDHRLECOTMOLeader
Larger companyMarket capitalisation $165.27B $15.20B $260.72B TMO
Cheaper on earningsLower P/E, profitable companies only 38.2x 26.4x 36.9x LECO
Cheaper on forward earningsLower price / next fiscal year consensus EPS 25.3x 24.5x 27.0x LECO
Faster revenue growthRevenue growth, trailing twelve months +5.5% +11.1% +8.3% LECO
More profitableNet margin, trailing twelve months 16.9% 12.4% 14.9% DHR
Better return on capitalReturn on invested capital 5.8% 22.6% 8.0% LECO
Less leveragedLower net debt / EBITDA 2.6x 1.0x 3.1x LECO
Higher dividend yieldTrailing dividend yield 0.00% 0.01% 0.00% LECO
Better 1-year returnPrice return, last 12 months +7.5% +22.7% +23.6% TMO
Better 5-year returnAnnualised price return, 5 years -5.5%/yr +14.9%/yr +1.8%/yr LECO
Less volatileAnnualised volatility, 1 year 30.7% 31.0% 30.0% TMO
Higher overall scoreMean of the five percentile scores vs peers 60/100 56/100 59/100 DHR

Percentile Scorecard

DHRLECOTMO

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisDHRLECOTMO
Valuation 71 #67 of 229 36 #131 of 204 60 #92 of 229
Growth 26 #163 of 221 47 #101 of 191 39 #135 of 221
Profitability 86 #30 of 209 94 #13 of 189 82 #39 of 209
Financial Health 47 #127 of 240 46 #119 of 221 31 #166 of 240
Shareholder Returns 71 #43 of 147 55 #71 of 158 82 #28 of 147
Overall 60 56 59
  • DHR ranked among 248 companies in Medical Devices and Diagnostics
  • LECO ranked among 223 companies in Machinery
  • TMO ranked among 248 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodDHRLECOTMOSPY
1 month +7.5%+3.7%+6.6% -2.0%
3 months +18.1%+2.5%+23.8% -2.2%
6 months +31.8%+6.7%+49.6% +4.2%
Year to date +0.5%+18.7%+20.5% +10.6%
1 year +7.5%+22.7%+23.6% +10.4%
3 years +16.3%+54.7%+53.6% +73.6%
3 years, per year +5.2%+15.7%+15.4% +20.2%
5 years -24.8%+100.0%+9.2% +61.6%
5 years, per year -5.5%+14.9%+1.8% +10.1%
10 years +200.6%+344.6%+378.1% +261.3%
10 years, per year +11.6%+16.1%+16.9% +13.7%

Risk

MeasureDHRLECOTMOSPY
Volatility, 1Y 30.7%31.0%30.0% 12.8%
Downside volatility, 1Y 31.8%31.3%28.6% 12.8%
Beta vs S&P 500, 1Y 0.481.190.64 1.00
Return / volatility, 1Y 0.240.730.79 0.81
Max drawdown, 5Y -50.8%-35.3%-41.5% -25.4%
From 52-week high -4.9%-4.8%-1.5% -3.2%
52-week high $242.05$298.88$709.29 $779.14
52-week low $161.91$220.64$438.34 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleDHRLECOTMO
P/E now vs peer median 37.4xmedian 28.1x 26.9xmedian 25.4x 36.6xmedian 28.1x
P/S now vs peer median 6.3xmedian 2.9x 3.3xmedian 1.9x 5.5xmedian 2.9x
EV/EBITDA now vs peer median 23.3xmedian 18.0x 18.0xmedian 14.5x 25.4xmedian 18.0x
P/FCF now vs peer median 28.3xmedian 24.8x 30.1xmedian 23.6x 34.1xmedian 24.8x
P/B now vs peer median 3.0xmedian 2.3x 9.9xmedian 2.2x 4.7xmedian 2.3x
PEG now vs peer median -4.66median 0.95 3.85median 1.21 4.84median 0.95

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsDHRLECOTMO
Revenue $25.61B $4.64B $47.35B
Gross profit $15.01B $1.65B $19.45B
Operating income $5.22B $802.52M $8.47B
Net income $4.33B $575.27M $7.09B
Free cash flow $5.73B $511.89M $7.60B
R&D $1.67B – $1.40B
EPS (diluted) $6.13 $10.48 $19.06
Cash & equivalents $5.68B $283.24M $5.46B
Total debt $26.48B $1.15B $41.37B
Shares (diluted) 706.80M 54.87M 371.00M
Enterprise value $144.92B $14.07B $237.23B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricDHRLECOTMO
P/E 37.4x 26.9x 36.6x
P/FCF 28.3x 30.1x 34.1x
P/Operating cash flow 23.6x 23.1x 27.8x
P/S 6.3x 3.3x 5.5x
P/B 3.0x 9.9x 4.7x
P/Tangible book 5.0x 9.9x 7.1x
EV/EBITDA 23.3x 18.0x 25.4x
EV/EBIT 35.0x 20.3x 34.7x
EV/Revenue 7.1x 3.5x 6.2x
EV/FCF 31.9x 31.8x 38.7x
EV/Operating cash flow 26.6x 24.4x 31.5x
PEG (3Y EPS CAGR) -4.66 3.85 4.84

Growth

14 metrics
MetricDHRLECOTMO
Revenue growth (1Y) 5.5% 11.1% 8.3%
Revenue CAGR (3Y) 1.3% 4.5% 2.9%
Gross profit growth (1Y) 3.9% 7.7% 7.8%
Gross profit CAGR (3Y) 1.2% 5.5% 4.0%
Operating income growth (1Y) 13.1% 12.9% 12.8%
Operating income CAGR (3Y) -3.8% 7.0% 7.2%
Net income growth (1Y) 23.6% 9.6% 7.9%
Net income CAGR (3Y) -9.9% 4.9% 6.2%
EPS growth (1Y) 24.8% 11.0% 9.7%
EPS CAGR (3Y) -8.0% 7.0% 7.6%
Operating cash flow growth (1Y) 8.6% 0.7% 21.9%
Operating cash flow CAGR (3Y) -5.3% 0.5% 4.5%
Free cash flow growth (1Y) 14.2% -6.3% 24.3%
Free cash flow CAGR (3Y) -5.8% -3.6% 5.1%

Profitability

14 metrics
MetricDHRLECOTMO
Gross margin 58.6% 35.5% 41.1%
EBITDA margin 30.7% 19.5% 24.4%
Operating margin 20.4% 17.3% 17.9%
Pretax margin 18.8% 16.2% 16.7%
Net margin 16.9% 12.4% 14.9%
FCF margin 22.4% 11.0% 16.0%
Operating cash flow margin 26.8% 14.4% 19.7%
Return on equity 8.2% 37.0% 13.2%
Return on assets 4.7% 14.9% 6.2%
Return on invested capital 5.8% 22.6% 8.0%
Return on capital employed 6.2% 27.7% 8.5%
Asset turnover 0.3x 1.2x 0.4x
Cash conversion (OCF / net income) 1.6x 1.2x 1.3x
Stock comp / revenue 1.3% 0.5% 0.7%

Financial Health

11 metrics
MetricDHRLECOTMO
Debt / assets 28.4% 29.5% 36.2%
Debt / equity 0.5x 0.7x 0.8x
Net debt / EBITDA 2.6x 1.0x 3.1x
Debt / FCF 4.6x 2.2x 5.4x
Liabilities / assets 42.5% 60.1% 52.1%
Equity / assets 57.5% 39.9% 47.9%
Interest coverage 14.5x – 5.5x
Current ratio 1.6x 1.9x 1.8x
Quick ratio 1.1x 1.0x 1.2x
Cash ratio 0.6x 0.3x 0.4x
Altman Z-score 3.72 7.77 4.17

Shareholder Returns

7 metrics
MetricDHRLECOTMO
Dividend yield 0.7% 1.1% 0.3%
Net buyback yield 0.6% 1.8% 1.6%
Shareholder yield 1.2% 2.9% 1.8%
Payout ratio (earnings) – 30.0% 9.5%
Payout ratio (FCF) – 33.7% 8.9%
Dividend growth (1Y) – 3.5% 8.0%
Dividend CAGR (3Y) – 6.3% 10.1%

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusDHRLECOTMO
Forward P/E 25.3xFY2026 24.5xFY2026 27.0xFY2026
EPS, next fiscal year $9.11FY2026 $11.62FY2026 $25.91FY2026
EPS growth, next FY +16.8%FY2026 +17.7%FY2026 +13.3%FY2026
EPS growth, the year after +8.0% +0.4% +2.0%
Revenue, next fiscal year $27.01BFY2026 $4.84BFY2026 $50.12BFY2026
Revenue growth, next FY +9.9%FY2026 +14.5%FY2026 +12.5%FY2026
Revenue growth, the year after -1.9% +5.5% -2.8%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersDHRLECOTMO
Held by institutions 81.9% 81.3% 90.2%
Institutions holding 2,120 705 2,627
Change in shares held, QoQ +1.1% +5.5% +0.8%
Institutions buying 842 299 1,145
Institutions selling 1,015 266 1,145
Buyers to sellers 0.83 1.12 1.00

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

DHRLECOTMO
DHR 1.00 0.22 0.72
LECO 0.22 1.00 0.20
TMO 0.72 0.20 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, DHR, LECO and TMO?

Thermo Fisher Scientific (TMO) is the largest by market capitalisation: Danaher (DHR) $165.27B, Lincoln Electric Holdings (LECO) $15.20B, Thermo Fisher Scientific (TMO) $260.72B.

Which stock is cheaper, DHR, LECO and TMO?

Lincoln Electric Holdings (LECO) trades on the lowest price-to-earnings ratio (Danaher (DHR) 38.2x, Lincoln Electric Holdings (LECO) 26.4x, Thermo Fisher Scientific (TMO) 36.9x). On next year's consensus earnings, Lincoln Electric Holdings (LECO) is cheapest (Danaher (DHR) 25.3x, Lincoln Electric Holdings (LECO) 24.5x, Thermo Fisher Scientific (TMO) 27.0x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Lincoln Electric Holdings (LECO) grew revenue fastest over the trailing twelve months: Danaher (DHR) +5.5%, Lincoln Electric Holdings (LECO) +11.1%, Thermo Fisher Scientific (TMO) +8.3%.

Which company is more profitable?

Danaher (DHR) has the highest net margin (Danaher (DHR) 16.9%, Lincoln Electric Holdings (LECO) 12.4%, Thermo Fisher Scientific (TMO) 14.9%). On return on invested capital, Lincoln Electric Holdings (LECO) leads (Danaher (DHR) 5.8%, Lincoln Electric Holdings (LECO) 22.6%, Thermo Fisher Scientific (TMO) 8.0%).

Which stock has performed better?

Over the past year Thermo Fisher Scientific (TMO) returned the most: Danaher (DHR) +7.5%, Lincoln Electric Holdings (LECO) +22.7%, Thermo Fisher Scientific (TMO) +23.6%. Over five years, Lincoln Electric Holdings (LECO) compounded fastest (Danaher (DHR) -5.5%/yr, Lincoln Electric Holdings (LECO) +14.9%/yr, Thermo Fisher Scientific (TMO) +1.8%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Lincoln Electric Holdings (LECO) has the highest dividend yield: Danaher (DHR) 0.00%, Lincoln Electric Holdings (LECO) 0.01%, Thermo Fisher Scientific (TMO) 0.00%. Danaher (DHR) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Thermo Fisher Scientific (TMO) has been the steadiest (Danaher (DHR) 30.7%, Lincoln Electric Holdings (LECO) 31.0%, Thermo Fisher Scientific (TMO) 30.0%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, DHR, LECO and TMO?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Lincoln Electric Holdings (LECO) leads on 7. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.